Sudden Sensorineural Hearing Loss Post Coronavirus Disease: A Systematic Review of Case Reports

Umashankar, Abishek; Prakash, Praveen; Prabhu, Prashanth

doi:10.1007/s12070-021-02756-w

Cited by 19 publications

(22 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The only previous systematic reviews available in the literature on this topic were two analyses of case reports [ 47 , 48 ] published in 2021, at earlier stages of clinical research on COVID-19, and one systematic review recently published that settled general inclusion/exclusion criteria (mainly related to the type of manuscript without considering any diagnostic standards) and only applied a qualitative approach [ 49 ].…”

Section: Discussionmentioning

confidence: 99%

Sudden Sensorineural Hearing Loss in the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

et al. 2022

View full text Add to dashboard Cite

Introduction: Accumulating data indicate that patients with COVID-19 could be affected by sudden sensorineural hearing loss (SSNHL). The aim of the study was to analyze the epidemiological and clinical trend of SSNHL occurrence during the COVID-19 pandemic by applying a systematic review and meta-analysis approach. Methods: PubMed, Scopus, Web of Science, ScienceDirect, and Cochrane databases were searched. Results: The seven included studies had adequate relevance to the topic and the quality was fair. The mean age at SSNHL onset ranged from 39.23 to 62.18 years during the pandemic year period (PYP); a meta-analysis of four studies comparing these data with those of previous periods in the same institutions found a younger age during the PYP (pooled mean −0.2848). The heterogeneity was high (76.1935%) and no frank asymmetry was observed in the funnel plot. The SARS-CoV-2 positivity rate of SSNHL patients ranged from 0% to 57.53%. Standard steroid treatments were applied without significant adverse effects. Comprehensively, hearing improvement was achieved for more than half of the cases. No studies reported long-term follow-up data. Conclusions: Further prospective analyses on large series and a long-term follow up on COVID-related SSNHL cases are necessary to address the open questions regarding the causative link between COVID-19 infection and SSNHL.

show abstract

Section: Discussionmentioning

confidence: 99%

Sudden Sensorineural Hearing Loss in the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Postulated causes of idiopathic SSNHL include viral cochleitis, cochlear membrane disruption, microvascular occlusion, autoimmune disorders [32]. Another rarely mentioned postulated cause of idiopathic SSNHL might be acute URIs contributing to inflammation-related cochleitis, a hypercoagulable state, and autoimmune disorders [32][33][34]. To investigate the association between acute URIs and SSNHL, we conducted a case-crossover study to estimate the risk of acute URIs for SSNHL.…”

Section: Discussionmentioning

confidence: 99%

Association of Acute Upper Respiratory Tract Infections with Sudden Sensorineural Hearing Loss: A Case-Crossover, Nationwide, Population-Based Cohort Study

Lin

Kuo

2021

IJERPH

View full text Add to dashboard Cite

The etiology of sudden sensorineural hearing loss (SSNHL) has been unclear until now. Understanding its potential etiology is crucial for the development of preventive medicine. In this study, we investigated the association between acute upper respiratory tract infections (URIs) and SSNHL risk. We conducted a case-crossover study by using the longitudinal health insurance database derived from the National Health Insurance Research Database in Taiwan. Individual acute URI between the case and control periods was reviewed. Multivariable conditional logistic regression models were used to estimate the adjusted odds ratios (aORs) of SSNHL risk associated with acute URIs after adjustments for potential confounders. In total, 1131 patients with SSNHL between 2010 and 2013 fulfilled our inclusion criteria and were included. The aOR (95% confidence interval [CI]) for SSNHL was 1.57 (1.20–2.05) in relation to acute URIs one month before the index date. Moreover, the aORs (95% CIs) of the female and young to middle-aged (≤65 years) populations were 1.63 (1.13–2.36) and 1.76 (1.29–2.40), respectively. In addition, the association between SSNHL and acute URIs was decreased over time. The aOR for SSNHL was 1.25 (1.01–1.56) in relation to acute URIs three months before the index date. A cute URIs increase SSNHL risk and are a potential risk factor for SSNHL. The establishment of a feasible health policy for the prevention of acute URIs is crucial for SSNHL prevention, particularly in female, and young to middle-aged populations.

show abstract

“…Ménière's Disease (MD) has historically been diagnosed primarily in people aged 40-60 (AHRF, 2022). Its effects on the inner ear include stiffening of the "hairs" (stereocilia) that line the cochlea, tinnitus, deafness, dizziness, vertigo and loss of balance that can lead to increased risk for falls [7,12]. Falls caused by MD typically occur without warning, loss of consciousness, or neurological symptoms and are known as drop attacks, Tumarkin drop attacks, drop vestibular attacks, or otolithic crises [12].…”

Section: Check For Updatesmentioning

confidence: 99%

“…

…”

mentioning

confidence: 99%

Long COVID and COVID-Induced Ménière's Disease: Overview and Recommendations

S¹,

Mahmoud²

2023

J Otolaryngol Rhinol

View full text Add to dashboard Cite

SARS-CoV-2, the infectious agent causing the ongoing COVID-19 pandemic, often has long-term impacts on the health of those who survive initial infection [1][2][3][4][5][6] and can lead to premature death [1]. An understudied outcome of COVID-19 is its effect on the audiovestibular system [7,8]. Impacts of the virus on this system create a pattern of disability similar to that of Ménière's Disease (MD), a progressively degenerative condition that can cause severe falls and deafness [1]. COVID-induced MD (CMD) impacts physical, social, psychological, financial, and other dimensions of health in profound ways that must be addressed throughout public and individualized health systems as early in its course as possible in order to increase individuals' quality of life and decrease costs to individuals and society. In this paper, we define "post-COVID syndrome," describe MD in more detail, and provide additional information on how MD impacts health, quality of life, and potential social and economic costs of COVID-19-induced MD (CMD). We also discuss options for early detection and intervention. Finally, we provide suggestions for public-and communitybased health approaches to addressing MD and COVID-19-originated MD (CMD) that focus on early detection and intervention, provider education, integrated treatment options that include use of interdisciplinary teams and paraprofessionals, fall prevention, and future avenues for research. LitErAturE rEviEw Check for updatesMénière's Disease (MD) has historically been diagnosed primarily in people aged 40-60 (AHRF, 2022). Its effects on the inner ear include stiffening of the "hairs" (stereocilia) that line the cochlea, tinnitus, deafness, dizziness, vertigo and loss of balance that can lead to increased risk for falls [7,12]. Falls caused by MD typically occur without warning, loss of consciousness, or neurological symptoms and are known as drop attacks, Tumarkin drop attacks, drop vestibular attacks, or otolithic crises [12]. These can be severe, especially before MD/CMD is identified, and early in symptom

show abstract

Sudden Sensorineural Hearing Loss Post Coronavirus Disease: A Systematic Review of Case Reports

Cited by 19 publications

References 35 publications

Sudden Sensorineural Hearing Loss in the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Sudden Sensorineural Hearing Loss in the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Association of Acute Upper Respiratory Tract Infections with Sudden Sensorineural Hearing Loss: A Case-Crossover, Nationwide, Population-Based Cohort Study

Long COVID and COVID-Induced Ménière's Disease: Overview and Recommendations

Contact Info

Product

Resources

About